Overview

Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The study estimates the efficacy and safety of MK0476 and aminophylline intravenous administration in adult participants with acute asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Aminophylline
Montelukast
Theophylline